Debt Default (new) — Company is in default on $11 million senior convertible note with multiple covenant breaches; lender forbearance expires June 30, 2026.
Forbearance Agreement (new) — Forbearance agreement with Alto Opportunity Master Fund indicates financial stress and covenant compliance issues.

NYSE: APUS Apimeds Pharmaceuticals US, Inc. 8-K

Apimeds settles merger disputes, discloses $11M debt default with forbearance through June 30

Filed May 4, 2026 · Period ending April 24, 2026 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade APUS commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 2, 2026 5:18 PM